ZTS
60
6
AEP
61
5
BWA
38
-2
SE
55
12
PFG
46
-2
A
27
-4
EMC
89
-8
RL
73
-2
FOXA
37
-2
AAL
35
2
TGNA
62
-2
CFG
40
-2
AIZ
63
6
GILD
45
2
WAT
36
-2
ETR
49
2
HD
47
-2
RIG
35
4
CVS
44
-5
CB
53
2
ZTS
60
6
AEP
61
5
BWA
38
-2
SE
55
12
PFG
46
-2
A
27
-4
EMC
89
-8
RL
73
-2
FOXA
37
-2
AAL
35
2
TGNA
62
-2
CFG
40
-2
AIZ
63
6
GILD
45
2
WAT
36
-2
ETR
49
2
HD
47
-2
RIG
35
4
CVS
44
-5
CB
53
2
Financhill
Back

Arcturus Therapeutics Holdings Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
32

ARCT
Arcturus Therapeutics Holdings

Last Price:
23.67
Seasonality Move:
20.41%
Buy
51

ALNY
Alnylam Pharmaceuticals

Last Price:
243.20
Seasonality Move:
20.36%
Sell
32
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?

  • The current Arcturus Therapeutics Holdings [ARCT] share price is $24.45. The Score for ARCT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ARCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $247.00. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ARCT Stock Price Chart

What is Arcturus Therapeutics Holdings's stock price today?

  • The Arcturus Therapeutics Holdings share price today is $24.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $247.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.

ARCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 34.68 Sell
Chaikin Money Flow: 75725 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.82 - 38.46) Sell
Bollinger Bands (100): (27.93 - 37.91) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 20.83 Buy
Relative Strength Index (14 RSI): 90.67 Buy
Chaikin Money Flow: -365678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (135.21 - 198.95) Buy
Bollinger Bands (100): (137.63 - 173.99) Buy

ARCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.33 Sell
20-day SMA: 32.34 Sell
50-day SMA: 30.17 Sell
200-day SMA: 29.65 Sell
8-day EMA: 26.79 Sell
20-day EMA: 29.57 Sell
50-day EMA: 30.93 Sell
200-day EMA: 30.27 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 198.72 Buy
20-day SMA: 171.59 Buy
50-day SMA: 157.67 Buy
200-day SMA: 165.81 Buy
8-day EMA: 210.85 Buy
20-day EMA: 183.04 Buy
50-day EMA: 165.87 Buy
200-day EMA: 167.34 Buy

Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.08 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.63 per share, and an increase next year of $1.19 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.

Arcturus Therapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):